Trial intelligence / Profile preview

Hydroxyethyl starch (Voluven) for treatment of hemorrhagic shock

IRCT2014052114190N3Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Sep 2013
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of Volulyte in hemorrhagic shock, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2013; status: completed.

02

Drugs

Volulyte
03

Conditions

hemorrhagic shock

Beyond the preview

Go deeper on IRCT2014052114190N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014052114190N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call